BioDiscovery

Name

BioDiscovery

Legal name

Bionano Genomics, Inc.

Website

https://biodiscovery.com

Company type

Public

Founded year

1997

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Genomic Analysis Software

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)

SIC

Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

akta.pro secondary industries

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Genomic analysis software
• Optical genome mapping
• Structural variant detection
• Clinical cytogenetics solutions
• Nucleic acid purification

Headquarters

HQ city

El Segundo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. OGM Hardware Systems: Sale of optical genome mapping instruments including Stratys System and Saphyr System for genomic analysis. These are high-value capital equipment purchases for research and clinical laboratories.
2. Software Licenses and Subscriptions: Revenue from VIA software, Access software, and analysis solutions. Software provides data interpretation, integration with NGS and microarray data, and ongoing analysis capabilities.
3. Consumables and Kits: Recurring revenue from sample preparation kits, Ionic purification kits with G2 chemistry, and other consumables required for OGM workflows.
4. Data Services: OGM data services offered through Bionano Laboratories and Certified Service Providers for customers who prefer outsourced analysis rather than in-house processing.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

BioDiscovery develops scientific software and instrumentation for genetic research and genomic analysis. The company's portfolio includes optical genome mapping systems (Stratys, Saphyr) for structural variant detection, analysis software (VIA, Access, EnFocus) for integrating OGM, NGS, and microarray data, the Ionic nucleic acid purification system using isotachophoresis, and consumables and data services supporting end-to-end genomic workflows.

Product overview

Bionano offers a platform-plus-modules architecture centered on optical genome mapping (OGM) technology. The core systems include the Stratys™ System and Saphyr® System for genome-wide structural variant detection, supported by VIA™ Software and Access Software for data analysis and interpretation. Sample preparation and purification is handled through the Ionic® System and associated kits. The portfolio integrates Compute Solutions for data processing and EnFocus Analysis for focused examination. Bionano Laboratories and its network of Certified Service Providers offer data services and OGM expertise, creating an end-to-end solution from sample preparation through comprehensive genomic analysis.

Differentiator

Problem solved

Functional benefit

Products and services

• Stratys™ System Optical genome mapping system that reveals all classes of structural variants using digital precision in a rapid, highly automated workflow from sample preparation through primary data analysis. Designed for clinical and research laboratories.
• Saphyr® System Genome-wide detection and analysis platform for all classes of structural variants from ultra-high molecular weight DNA using optical genome mapping technology. Designed for research and clinical genomics laboratories.
• VIA™ Software Analysis software that receives and interprets data from optical genome mapping (OGM), next-generation sequencing (NGS) and microarrays to contextualize all classes of genomic variation in one view for comprehensive interpretation.
• Access Software Software product for data access and management in the genomic analysis workflow.
• Ionic® System Purification system that uses isotachophoresis (ITP) to isolate, purify, and concentrate genomic DNA and RNA from cells, tissue, and FFPE samples with Ionic G2 chemistry. Requires minimal hands-on time per sample.
• Ionic® Purification Kits Purification kits for use with the Ionic System, enabling DNA and RNA sample preparation with minimal hands-on time per sample.
• Sample Preparation Kits Kits for preparing samples for optical genome mapping analysis.
• Compute Solutions Computing infrastructure and solutions for processing optical genome mapping data at scale.
• EnFocus Analysis Analysis tool for focused examination of genomic data in optical genome mapping workflows.
• OGM Data Services Data services offering for optical genome mapping analysis provided by Bionano Laboratories and a network of Certified Service Providers, for customers who prefer outsourced analysis rather than in-house processing.

Quantifiable outcome

• Over 500 publications cite OGM solutions demonstrating scientific validation

Named customers1 record

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Two partnerships are on record, tiered core and flagship.

• RevvitycoreGTM or Marketing Partner · 20 June 2024Bionano announced a software marketing agreement with Revvity for newborn sequencing research. Revvity, a company focused on reproductive and prenatal health, will market Bionano's software solutions in connection with newborn sequencing research initiatives.
• DiagensflagshipStrategic or Co-development Partner · 17 April 2024Bionano and Diagens signed a partnership to commercialize the first ever clinical cytogenetic analysis that combines OGM and Artificial Intelligence. This strategic partnership integrates Diagens' AI capabilities with Bionano's OGM technology to advance clinical cytogenetics applications.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Illumina: Dominant NGS platform vendor whose short-read sequencing workflows overlap with Bionano's molecular genomics applications and compete for cytogenomics and oncology research budgets.
• Agilent Technologies: Analytical laboratory instruments and genomics solutions provider with overlapping customer base in molecular genomics, cytogenetics, and clinical research labs.
• Revvity (formerly PerkinElmer): Life sciences and diagnostics instruments company; both a Bionano software marketing partner and a broad incumbent in reproductive health and newborn screening workflows where OGM is now positioned.
• Bio-Techne: Supplies reagents, instruments, and assays used in molecular biology and genomics workflows that overlap with Bionano's cytogenomics and cell bioprocessing customers.

Regional players

• Natera: Molecular diagnostics company focused on reproductive health and oncology testing that overlaps with Bionano's genetic disease and oncology applications in the U.S. clinical market.

Emerging players

• NeoGenomics: Clinical oncology genomics laboratory that could either partner with or compete against Bionano Laboratories' OGM data services in hematological malignancy and solid tumor profiling.
• 10x Genomics: Genomics platform company offering linked-read and single-cell solutions that intersect with Bionano's structural variant and cell bioprocessing applications.
• Element Biosciences: Sequencing platform challenger whose lower-cost genomics systems compete for the same research and translational lab capital budgets as Bionano's OGM instruments.

Direct peers

• Pacific Biosciences (PacBio): Long-read sequencing platform that competes directly with OGM in detecting large structural variants and complex genomic rearrangements across research and clinical markets.
• Oxford Nanopore Technologies: Long-read sequencing provider whose platforms are an alternative to OGM for comprehensive structural variant detection and repeat-rich region analysis.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/biodiscoveryinc
• Facebookfacebook.com/biodiscoveryinc
• LinkedInlinkedin.com/company/biodiscovery

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioDiscovery